Department of Pathology, The Medical University of Vienna, Vienna, Austria.
ARCHIMED Life Science GmbH, Vienna, Austria.
Clin Genet. 2020 Apr;97(4):655-660. doi: 10.1111/cge.13694. Epub 2020 Jan 7.
A total of 11 948 females suspicious of Fabry disease were tested by a combined biochemical and genetic approach. The enzyme activity, together with the concentration of lyso-GL-3 (lyso-Gb3) biomarker in dried blood spots (DBS), substantially improved the diagnostic detection of Fabry disease in females compared to the enzyme activity alone. Abnormal values for both were highly suspicious of Fabry disease (97% positive predictive value [PPV], similar to PPV in males). In cases with one abnormal biochemical value, elevated lyso-GL-3 is a far more important indicator than low enzyme activity (39% PPV vs 6% PPV). Cases with clearly negative results for both biochemical parameters are unlikely to have Fabry disease, even in clinically highly suspicious cases.
共有 11948 名疑似法布里病的女性接受了联合生化和基因检测。与单独检测酶活性相比,酶活性与干血斑(DBS)中溶葡糖苷酶-3(lyso-Gb3)生物标志物的浓度相结合,大大提高了女性法布里病的诊断检出率。两种指标的异常值均高度提示法布里病(97%的阳性预测值[PPV],与男性相似)。在仅有一项生化指标异常的情况下,溶葡糖苷酶-3 的升高比酶活性降低更重要(39%的 PPV 比 6%的 PPV)。两种生化参数均明确为阴性的病例不太可能患有法布里病,即使在临床高度疑似的病例中也是如此。